• Something wrong with this record ?

Altered Steroidome in Women with Multiple Sclerosis

R. Kancheva, M. Hill, M. Velíková, L. Kancheva, J. Včelák, R. Ampapa, M. Židó, I. Štětkářová, J. Libertínová, M. Vosátková, E. Kubala Havrdová

. 2024 ; 25 (22) : . [pub] 20241108

Language English Country Switzerland

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc25003491

Grant support
NU20-04-00450 Agentura Pro Zdravotnický Výzkum České Republiky

Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system (CNS) mainly afflicting young women. Various steroids can influence the onset and development of the disease or, on the contrary, mitigate its course; however, a systematic review of steroidomic changes in MS patients is lacking. Based on the gas chromatography tandem mass spectrometry (GC-MS/MS) platform and, in the case of estradiol, also using immunoassay, this study performed a comprehensive steroidomic analysis in 25 female MS patients aged 39(32, 49) years compared to 15 female age-matched controls aged 38(31, 46) years. A significant trend towards higher ratios of conjugated steroids to their unconjugated counterparts was found in patients, which is of particular interest in terms of the balance between excitatory and inhibitory steroid modulators of ionotropic receptors. Patients showed altered metabolic pathway to cortisol with decreased conversion of pregnenolone to 17-hydroxypregnenolone and 17-hydroxypregnenolone to 17-hydroxyprogesterone and increased conversion of 17-hydroxypregnenolone to dehydroepiandrosterone (DHEA), resulting in lower levels of 17-hydroxyprogesterone, as well as indications of impaired conversion of 11-deoxy-steroids to 11β-hydroxy-steroids but reduced conversion of cortisol to cortisone. Due to over-activation of hypothalamic-pituitary-adrenal axis (HPAA), however, cortisol and cortisone levels were higher in patients with indications of depleted cortisol synthesizing enzymes. Patients showed lower conversion of DHEA to androstenedione, androstenedione to testosterone, androstenedione to estradiol in the major pathway, and testosterone to estradiol in the minor pathway for estradiol synthesis at increased conversion of androstenedione to testosterone. They also showed lower conversion of immunoprotective Δ5 androstanes to their more potent 7α/β-hydroxy metabolites and had lower circulating allopregnanolone and higher ratio 3β-hydroxy-steroids to their neuroprotective 3α-hydroxy-counterparts.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25003491
003      
CZ-PrNML
005      
20250206104356.0
007      
ta
008      
250121s2024 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/ijms252212033 $2 doi
035    __
$a (PubMed)39596101
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Kancheva, Radmila $u Institute of Endocrinology, 11000 Prague, Czech Republic
245    10
$a Altered Steroidome in Women with Multiple Sclerosis / $c R. Kancheva, M. Hill, M. Velíková, L. Kancheva, J. Včelák, R. Ampapa, M. Židó, I. Štětkářová, J. Libertínová, M. Vosátková, E. Kubala Havrdová
520    9_
$a Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system (CNS) mainly afflicting young women. Various steroids can influence the onset and development of the disease or, on the contrary, mitigate its course; however, a systematic review of steroidomic changes in MS patients is lacking. Based on the gas chromatography tandem mass spectrometry (GC-MS/MS) platform and, in the case of estradiol, also using immunoassay, this study performed a comprehensive steroidomic analysis in 25 female MS patients aged 39(32, 49) years compared to 15 female age-matched controls aged 38(31, 46) years. A significant trend towards higher ratios of conjugated steroids to their unconjugated counterparts was found in patients, which is of particular interest in terms of the balance between excitatory and inhibitory steroid modulators of ionotropic receptors. Patients showed altered metabolic pathway to cortisol with decreased conversion of pregnenolone to 17-hydroxypregnenolone and 17-hydroxypregnenolone to 17-hydroxyprogesterone and increased conversion of 17-hydroxypregnenolone to dehydroepiandrosterone (DHEA), resulting in lower levels of 17-hydroxyprogesterone, as well as indications of impaired conversion of 11-deoxy-steroids to 11β-hydroxy-steroids but reduced conversion of cortisol to cortisone. Due to over-activation of hypothalamic-pituitary-adrenal axis (HPAA), however, cortisol and cortisone levels were higher in patients with indications of depleted cortisol synthesizing enzymes. Patients showed lower conversion of DHEA to androstenedione, androstenedione to testosterone, androstenedione to estradiol in the major pathway, and testosterone to estradiol in the minor pathway for estradiol synthesis at increased conversion of androstenedione to testosterone. They also showed lower conversion of immunoprotective Δ5 androstanes to their more potent 7α/β-hydroxy metabolites and had lower circulating allopregnanolone and higher ratio 3β-hydroxy-steroids to their neuroprotective 3α-hydroxy-counterparts.
650    _2
$a lidé $7 D006801
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a dospělí $7 D000328
650    12
$a roztroušená skleróza $x metabolismus $x krev $7 D009103
650    _2
$a lidé středního věku $7 D008875
650    _2
$a steroidy $x metabolismus $7 D013256
650    _2
$a plynová chromatografie s hmotnostně spektrometrickou detekcí $7 D008401
650    _2
$a tandemová hmotnostní spektrometrie $7 D053719
650    _2
$a hydrokortison $x metabolismus $x krev $7 D006854
650    _2
$a studie případů a kontrol $7 D016022
655    _2
$a časopisecké články $7 D016428
700    1_
$a Hill, Martin $u Institute of Endocrinology, 11000 Prague, Czech Republic $1 https://orcid.org/0000000217050835 $7 mzk2005304431
700    1_
$a Velíková, Marta $u Institute of Endocrinology, 11000 Prague, Czech Republic
700    1_
$a Kancheva, Ludmila $u Institute of Endocrinology, 11000 Prague, Czech Republic
700    1_
$a Včelák, Josef $u Institute of Endocrinology, 11000 Prague, Czech Republic $1 https://orcid.org/0000000265460580 $7 xx0107261
700    1_
$a Ampapa, Radek $u MS Center, Jihlava Hospital, 58633 Jihlava, Czech Republic
700    1_
$a Židó, Michal $u Department of Neurology 3FM CU and UHKV, Third Faculty of Medicine, Charles University, 10000 Prague, Czech Republic
700    1_
$a Štětkářová, Ivana $u Department of Neurology 3FM CU and UHKV, Third Faculty of Medicine, Charles University, 10000 Prague, Czech Republic $1 https://orcid.org/0000000326991124 $7 xx0030376
700    1_
$a Libertínová, Jana $u MS Center, Second Faculty of Medicine, Charles University, 15006 Prague, Czech Republic
700    1_
$a Vosátková, Michala $u Institute of Endocrinology, 11000 Prague, Czech Republic
700    1_
$a Kubala Havrdová, Eva $u Department of Neurology, First Faculty of Medicine, Charles University, 12008 Prague, Czech Republic $1 https://orcid.org/0000000295434359 $7 nlk19990073204
773    0_
$w MED00176142 $t International journal of molecular sciences $x 1422-0067 $g Roč. 25, č. 22 (2024)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39596101 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250121 $b ABA008
991    __
$a 20250206104352 $b ABA008
999    __
$a ok $b bmc $g 2263326 $s 1239498
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 25 $c 22 $e 20241108 $i 1422-0067 $m International journal of molecular sciences $n Int J Mol Sci $x MED00176142
GRA    __
$a NU20-04-00450 $p Agentura Pro Zdravotnický Výzkum České Republiky
LZP    __
$a Pubmed-20250121

Find record

Citation metrics

Archiving options